BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8298813)

  • 1. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia.
    Ferreira SH; Lorenzetti BB; Poole S
    Br J Pharmacol; 1993 Nov; 110(3):1227-31. PubMed ID: 8298813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia.
    Poole S; Lorenzetti BB; Cunha JM; Cunha FQ; Ferreira SH
    Br J Pharmacol; 1999 Feb; 126(3):649-56. PubMed ID: 10188975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone.
    Ferreira SH; Cunha FQ; Lorenzetti BB; Michelin MA; Perretti M; Flower RJ; Poole S
    Br J Pharmacol; 1997 Jul; 121(5):883-8. PubMed ID: 9222544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinin release of TNF-alpha plays a key role in the development of inflammatory hyperalgesia.
    Ferreira SH; Lorenzetti BB; Cunha FQ; Poole S
    Agents Actions; 1993; 38 Spec No():C7-9. PubMed ID: 8317326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10.
    Poole S; Cunha FQ; Selkirk S; Lorenzetti BB; Ferreira SH
    Br J Pharmacol; 1995 Jun; 115(4):684-8. PubMed ID: 7582491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor.
    Cunha TM; Verri WA; Fukada SY; Guerrero AT; Santodomingo-Garzón T; Poole S; Parada CA; Ferreira SH; Cunha FQ
    Eur J Pharmacol; 2007 Nov; 573(1-3):221-9. PubMed ID: 17669394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-13.
    Lorenzetti BB; Poole S; Veiga FH; Cunha FQ; Ferreira SH
    Eur Cytokine Netw; 2001; 12(2):260-7. PubMed ID: 11399514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist.
    Cunha JM; Cunha FQ; Poole S; Ferreira SH
    Br J Pharmacol; 2000 Jul; 130(6):1418-24. PubMed ID: 10903985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia.
    Cunha FQ; Poole S; Lorenzetti BB; Ferreira SH
    Br J Pharmacol; 1992 Nov; 107(3):660-4. PubMed ID: 1472964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4.
    Cunha FQ; Poole S; Lorenzetti BB; Veiga FH; Ferreira SH
    Br J Pharmacol; 1999 Jan; 126(1):45-50. PubMed ID: 10051119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-induced neutrophil chemoattractant 1 (CINC-1) mediates the sympathetic component of inflammatory mechanical hypersensitivitiy in rats.
    Lorenzetti BB; Veiga FH; Canetti CA; Poole S; Cunha FQ; Ferreira SH
    Eur Cytokine Netw; 2002; 13(4):456-61. PubMed ID: 12517731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor-alpha, interleukin-1beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity.
    Sachs D; Cunha FQ; Poole S; Ferreira SH
    Pain; 2002 Mar; 96(1-2):89-97. PubMed ID: 11932065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat.
    Davis AJ; Perkins MN
    Br J Pharmacol; 1994 Sep; 113(1):63-8. PubMed ID: 7812634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats.
    Chichorro JG; Lorenzetti BB; Zampronio AR
    Br J Pharmacol; 2004 Apr; 141(7):1175-84. PubMed ID: 15006904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2X3 and P2X2/3 receptors mediate mechanical hyperalgesia induced by bradykinin, but not by pro-inflammatory cytokines, PGE₂ or dopamine.
    de Oliveira Fusaro MC; Pelegrini-da-Silva A; Araldi D; Parada CA; Tambeli CH
    Eur J Pharmacol; 2010 Dec; 649(1-3):177-82. PubMed ID: 20868656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia.
    Cunha FQ; Teixeira MM; Ferreira SH
    Br J Pharmacol; 1999 Jun; 127(3):671-8. PubMed ID: 10401557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a kinin B2 receptor antagonist on LPS- and cytokine-induced neutrophil migration in rats.
    Santos DR; Calixto JB; Souza GE
    Br J Pharmacol; 2003 May; 139(2):271-8. PubMed ID: 12770932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-8 as a mediator of sympathetic pain.
    Cunha FQ; Lorenzetti BB; Poole S; Ferreira SH
    Br J Pharmacol; 1991 Nov; 104(3):765-7. PubMed ID: 1797337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug modulation of antigen-induced paw oedema in guinea-pigs: effects of lipopolysaccharide, tumour necrosis factor and leucocyte depletion.
    da Motta JI; Cunha FQ; Vargaftig BB; Ferreira SH
    Br J Pharmacol; 1994 May; 112(1):111-6. PubMed ID: 8032630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral P2X7 receptor-induced mechanical hyperalgesia is mediated by bradykinin.
    Teixeira JM; de Oliveira-Fusaro MC; Parada CA; Tambeli CH
    Neuroscience; 2014 Sep; 277():163-73. PubMed ID: 24997266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.